Key result
Point-of-care haemoglobin estimation using Pronto-7 and HemoCue showed fixed biases of +1.18 g/dl and -0.01 g/dl compared to laboratory analysis, with wide 95% prediction limits for both devices.
Why the study?
Do point-of-care devices (Pronto-7 and HemoCue) accurately estimate hemoglobin compared to an automated laboratory analyzer in pregnant women?
Observational (n=141)
Do point-of-care devices (Pronto-7 and HemoCue) accurately estimate hemoglobin compared to an automated laboratory analyzer in pregnant women?
Both Pronto-7 and HemoCue point-of-care devices are imprecise with wide prediction limits for hemoglobin estimation compared to laboratory analysis.
Answers are grounded in this paper and cite their sources.
Wide prediction limits advise caution with Pronto-7 and HemoCue hemoglobin estimates in pregnancy; leaves open need for prospective device validation before clinical adoption.
We prospectively studied agreement in haemoglobin estimation between two point-of-care devices (Pronto-7(®) Pulse CO-Oximetry(™), Masimo Corporation, Irvine, California, USA and HemoCue(®) Hb 201 +, HemoCue, Angelholm, Sweden) and an automated laboratory analyser (Sysmex XE5000, Sysmex Corporation, Kobe, Japan). Venous blood sampling and finger co-oximeter readings were performed on 141 pregnant women undergoing routine mid-trimester haemoglobin assessment. Three replicate measures were performed and analysis used Bayesian-based variance component modelling to provide estimates of repeatability, between person within method bias and precision. Repeatability, assessed by coefficient of variation, was higher for Pronto-7(®) (2.3%) compared to HemoCue(®) (5.2%). Fixed bias (mean difference, device - laboratory) was +1.18 (standard deviation 1.19) g/dl and - 0.01 (standard deviation 1.34) g/dl for Pronto-7(®) and HemoCue(®) respectively, with no statistical evidence of proportional bias. Based upon a single device reading, the 95% prediction limits for Pronto-7(®) were -1.2 to 3.6 g.dl-1 and HemoCue(®) were -2.7 to 2.7 g/dl. For both devices precision was not meaningfully improved by averaging replicate readings. However, repeated readings may allow detection of aberrant results. Overall both devices are imprecise and 95% prediction limits wide. We present further prediction limits, derived from the posterior distribution and adjusted for any fixed bias for set levels of probability (certainty). These may be used to support clinical decisions when using these point-of-care devices.
No takes yet. Share an insight, caveat, or question.
Hiscock et al. (2014) conducted an observational in Haemoglobin assessment in pregnancy (n=141). Pronto-7 and HemoCue point-of-care devices vs. Automated laboratory analyser was evaluated on Agreement in haemoglobin estimation (fixed bias) (MD +1.18 g/dl (Pronto-7) and -0.01 g/dl (HemoCue)). Point-of-care haemoglobin estimation using Pronto-7 and HemoCue showed fixed biases of +1.18 g/dl and -0.01 g/dl compared to laboratory analysis, with wide 95% prediction limits for both devices.
Synapse has enriched 10 related papers. Consider them for comparative context: